Structures by: Bazgir A.
Total: 21
C31H20N4O2S3
C31H20N4O2S3
Org. Biomol. Chem. (2017)
a=12.844(4)Å b=13.059(3)Å c=17.671(6)Å
α=90.00° β=109.17(3)° γ=90.00°
C25H16N4O2S3
C25H16N4O2S3
Org. Biomol. Chem. (2017)
a=6.4503(16)Å b=12.709(3)Å c=16.510(4)Å
α=80.068(19)° β=88.626(19)° γ=82.085(19)°
C31H22O7S
C31H22O7S
Organic & biomolecular chemistry (2013) 11, 2 279-286
a=10.399(3)Å b=11.235(3)Å c=13.089(3)Å
α=107.753(19)° β=101.40(2)° γ=110.87(2)°
C25H21N3O6
C25H21N3O6
RSC Advances (2014) 4, 14 7296
a=9.6442(12)Å b=14.0350(13)Å c=15.9534(18)Å
α=90.00° β=91.025(9)° γ=90.00°
C13H9N3O3S2
C13H9N3O3S2
RSC Adv. (2015) 5, 103 85028
a=18.882(2)Å b=3.9209(5)Å c=20.007(2)Å
α=90.00° β=107.813(13)° γ=90.00°
C8H8N2OS2
C8H8N2OS2
RSC Adv. (2015) 5, 103 85028
a=15.8510(16)Å b=10.6692(5)Å c=13.4352(12)Å
α=90.00° β=124.182(9)° γ=90.00°
C9H12N4S3
C9H12N4S3
RSC Adv. (2015) 5, 103 85028
a=15.5299(17)Å b=7.0738(14)Å c=12.0531(17)Å
α=90.00° β=90.00° γ=90.00°
C23H10N5O2,C6H16N
C23H10N5O2,C6H16N
RSC Adv. (2016)
a=8.898(4)Å b=11.774(6)Å c=12.676(7)Å
α=80.45(4)° β=81.87(4)° γ=89.64(4)°
C26H16N6O2
C26H16N6O2
RSC Adv. (2016)
a=8.0008(11)Å b=11.6372(18)Å c=12.3753(18)Å
α=87.946(12)° β=72.447(11)° γ=85.708(12)°
Methyl N-[(2-hydroxynaphthalen-1-yl)(phenyl)methyl]carbamate
C19H17NO3
Acta Crystallographica Section E (2006) 62, 8 o3533-o3534
a=9.217(3)Å b=18.106(5)Å c=11.305(4)Å
α=90° β=121.11(2)° γ=90°
7-(Benzylsulfanyl)-5-(2-methoxyphenyl)-1,3-dimethyl-5,6-dihydropyrimido[4,5-\ <i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C22H22N4O3S
Acta Crystallographica Section E (2008) 64, 9 o1666
a=10.9216(9)Å b=8.8528(5)Å c=20.7263(15)Å
α=90° β=90.638(6)° γ=90°
5-Fluorophenyl-1,3,7,9-tetramethylpyrido[2,3-d:6,5-d]dipyrimidine- 2,4,6,8(1H,3H,7H,9H)-tetrone
C19H16FN5O4
Acta Crystallographica Section E (2007) 63, 6 o2790-o2790
a=9.074(2)Å b=10.930(3)Å c=20.091(5)Å
α=75.04(2)° β=76.82(2)° γ=70.93(2)°
2-Chloro-12-phenyl-6,7,8,9,10,11-hexahydrocycloocta[<i>b</i>]quinoline
C21H20Cl1N1
Acta Crystallographica Section E (2008) 64, 5 o831
a=9.837(2)Å b=9.980(2)Å c=10.175(2)Å
α=74.600(17)° β=70.575(16)° γ=61.829(15)°
3,3-Dimethyl-9-phenyl-3,4-dihydroacridin-1(2<i>H</i>)-one
C21H19NO
Acta Crystallographica Section E (2008) 64, 8 o1554
a=16.341(3)Å b=11.3889(18)Å c=18.772(4)Å
α=90° β=110.386(14)° γ=90°
7,11-Bis(4-methylphenyl)-2,4,8,10-tetraazaspiro[5.5]undecane-1,3,5,9-tetraone
C21H20N4O4
Acta Crystallographica Section E (2008) 64, 8 o1555
a=8.852(2)Å b=12.538(3)Å c=17.259(4)Å
α=90° β=104.483(18)° γ=90°
1-[(2-Hydroxynaphthalen-1-yl)(phenyl)methyl]-3-methylurea
C19H18N2O2
Acta Crystallographica Section E (2006) 62, 9 o3875-o3876
a=9.463(2)Å b=16.550(3)Å c=10.607(2)Å
α=90° β=107.191(16)° γ=90°
1-(4-Fluorophenyl)-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazin-3-one
C18H12FNO2
Acta Crystallographica Section E (2007) 63, 3 o1495-o1496
a=13.319(4)Å b=6.3601(15)Å c=17.331(6)Å
α=90° β=100.55(3)° γ=90°
N-[(2-hydroxynaphthalen-1-yl)(phenyl)methyl]benzamide
C24H19NO2
Acta Crystallographica Section E (2006) 62, 12 o5523-o5524
a=9.8517(17)Å b=11.3516(18)Å c=33.451(8)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl 2-(1-benzyl-2-oxoindolin-3-ylidene)-1,3-dithiole-4,5-dicarboxylate
C22H17N1O5S2
Acta Crystallographica Section E (2011) 67, 2 o482
a=28.923(2)Å b=9.3615(5)Å c=15.0531(12)Å
α=90° β=101.319(6)° γ=90°
Ethyl 2-methyl-4-phenylquinoline-3-carboxylate
C19H17N1O2
Acta Crystallographica Section E (2009) 65, 6 o1382
a=9.0282(10)Å b=9.3620(10)Å c=10.7258(10)Å
α=69.765(8)° β=66.733(8)° γ=70.605(8)°
C30H22N2O6Pd2S2,CH4O
C30H22N2O6Pd2S2,CH4O
New Journal of Chemistry (2021)
a=7.9107(16)Å b=12.229(2)Å c=30.953(6)Å
α=90.00° β=90.00° γ=90.00°